American Pharmaceutical Security Act

Summary

The bill orders the head of the Centers for Medicare & Medicaid Services to prepare a report on how Medicare and Medicaid coverage and reimbursement policies are used to protect the markets for active pharmaceutical ingredients and essential starting materials. The report is intended to give lawmakers insight into the impact of these policies on the drug ingredient supply chain. It affects CMS, drug manufacturers, and ultimately patients who rely on a stable supply of medicines.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share